{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:10:31Z","timestamp":1785391831975,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the practice of aminoglycoside use\/monitoring in Kenya and explore healthcare worker (HCW) perceptions of aminoglycoside monitoring to identify gaps and opportunities for future improvements, given the low therapeutic index of aminoglycosides.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a two-phase study whereby we reviewed patients\u2019 medical records at Kenyatta National Hospital (October\u2013December 2016) in Phase 1 and interviewed HCWs face to face in Phase 2. Outcome measures included describing and evaluating the practice of aminoglycoside use and monitoring and compliance to guidelines. Data were analysed using descriptive and inferential analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, out of the 2318 patients admitted, 192 patients (8.3%) were prescribed an aminoglycoside, of which 102 (53.1%) had aminoglycoside doses that did not conform to national guidelines. Aminoglycoside-related adverse effects were suspected in 65 (33.9%) patients. Monitoring of aminoglycoside therapy was performed in only 17 (8.9%) patients, with no therapeutic drug monitoring (TDM), attributed mainly to knowledge and skill gaps and lack of resources. Out of the 28 recruited HCWs, 18 (64.3%) needed training in how to perform and interpret TDM results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The practice of using and monitoring aminoglycosides was suboptimal, raising concerns around potential avoidable harm to patients. The identified gaps could form the basis for developing strategies to improve the future use of aminoglycosides, not only in Kenya but also in other countries with similar settings and resources.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlz087","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:10:29Z","timestamp":1575922229000},"source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries"],"prefix":"10.1093","volume":"2","author":[{"given":"Elias Joseph","family":"Onyango","sequence":"first","affiliation":[{"name":"University of Nairobi, PO Box 19676 NAIROBI - 00202 KNH, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Okalebo","sequence":"additional","affiliation":[{"name":"University of Nairobi, PO Box 19676 NAIROBI - 00202 KNH, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Oluka","sequence":"additional","affiliation":[{"name":"University of Nairobi, PO Box 19676 NAIROBI - 00202 KNH, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline","family":"Kinuthia","sequence":"additional","affiliation":[{"name":"Kenyatta National Hospital, PO Box 20723, Hospital Rd, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loice","family":"Achieng","sequence":"additional","affiliation":[{"name":"University of Nairobi, PO Box 19676 NAIROBI - 00202 KNH, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Godman","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ, Scotland"},{"name":"Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa"},{"name":"Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-1988","authenticated-orcid":false,"given":"Amanj","family":"Kurdi","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ, Scotland"},{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, Hawler Medical University, Erbil, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"2021052617251625200_dlz087-B1","year":"2015"},{"key":"2021052617251625200_dlz087-B2","first-page":"1","article-title":"Aminoglycoside-induced hearing deficits \u2013 a review of cochlear ototoxicity","volume":"6190","author":"Petersen","year":"2015","journal-title":"South African Fam Pract"},{"key":"2021052617251625200_dlz087-B3","first-page":"97","volume-title":"Applied Clinical Pharmacokinetics","author":"Murphy","year":"2008","edition":"2"},{"key":"2021052617251625200_dlz087-B4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00467-016-3533-z","article-title":"Aminoglycoside-induced nephrotoxicity in children","volume":"23","author":"McWilliam","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2021052617251625200_dlz087-B5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/peds.2012-0055I","article-title":"Age groups for pediatric trials","volume":"129","author":"Williams","year":"2012","journal-title":"Pediatrics."},{"key":"2021052617251625200_dlz087-B6","first-page":"6","year":"2016"},{"key":"2021052617251625200_dlz087-B7","first-page":"225","article-title":"Sample size calculation in epidemiological studies","volume":"7","author":"Kasiulevivcius","year":"2006","journal-title":"Gerantologija"},{"key":"2021052617251625200_dlz087-B8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhin.2004.07.026","article-title":"Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey","volume":"59","author":"Erbay","year":"2005","journal-title":"J Hosp Infect"},{"key":"2021052617251625200_dlz087-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-016-1414-6","article-title":"Assessment of medicines use pattern using World Health Organization\u2019s Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia","volume":"16","author":"Bilal","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2021052617251625200_dlz087-B10"},{"key":"2021052617251625200_dlz087-B11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/CA.S8424","article-title":"Can a gentamicin-specific chart reduce neonatal medication errors?","volume":"2","author":"Flannigan","year":"2010","journal-title":"Clin Audit"},{"key":"2021052617251625200_dlz087-B12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/1596-3519.68366","article-title":"Pattern of prescription drug use in Nigerian army hospitals","volume":"9","author":"Adebayo","year":"2010","journal-title":"Ann Afr Med"},{"key":"2021052617251625200_dlz087-B13"},{"key":"2021052617251625200_dlz087-B14"},{"key":"2021052617251625200_dlz087-B15","first-page":"2348","article-title":"Study of prescribing patterns of antimicrobial agents in the paediatric wards at tertiary teaching care hospital, Gujarat","volume":"3","author":"Prajapati","year":"2012","journal-title":"Int J Pharm Sci Res"},{"key":"2021052617251625200_dlz087-B16","first-page":"1","article-title":"Non-compliance in gentamicin prescribing and administration: a patient safety issue","volume":"305","author":"Murgitroyd","year":"2015","journal-title":"Cogent Med"},{"key":"2021052617251625200_dlz087-B17","first-page":"191","article-title":"Usage pattern and serum level measurement of amikacin in the internal medicine ward of the largest referral hospital in the south of Iran: a pharmacoepidemiological study","volume":"41","author":"Namazi","year":"2016","journal-title":"Iran J Med Sci"},{"key":"2021052617251625200_dlz087-B18","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.01430-08","article-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","volume":"53","author":"Oliveira","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2021052617251625200_dlz087-B19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/2229-5151.79277","article-title":"Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients","volume":"1","author":"Gerlach","year":"2011","journal-title":"Int J Crit Illn Inj Sci"},{"key":"2021052617251625200_dlz087-B20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2021052617251625200_dlz087-B21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1542\/peds.114.1.e111","article-title":"Extended-interval aminoglycoside administration for children: a meta-analysis","volume":"114","author":"Contopoulos-Ioannidis","year":"2004","journal-title":"J Pediatr"},{"key":"2021052617251625200_dlz087-B22","first-page":"308","author":"Kimotho"},{"key":"2021052617251625200_dlz087-B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jppr.1079","article-title":"Doctors\u2019 perspectives towards a bedside aminoglycoside therapeutic drug monitoring service: a collaboration between pharmacy and clinical pharmacology","volume":"45","author":"Phillips","year":"2015","journal-title":"Pharm Pract Res"},{"key":"2021052617251625200_dlz087-B24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2515\/therapie\/2011001","article-title":"Level of evidence for therapeutic drug monitoring of aminoglycosides","volume":"66","author":"Venisse","year":"2011","journal-title":"Therapie"},{"key":"2021052617251625200_dlz087-B25","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1016\/S0016-5085(17)31545-7","article-title":"Attitude and barriers towards the implementation of therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease clinical practice","volume":"152","author":"Grossberg","year":"2017","journal-title":"Gastroenterology"},{"key":"2021052617251625200_dlz087-B26","year":"2015"},{"key":"2021052617251625200_dlz087-B27"},{"key":"2021052617251625200_dlz087-B28"},{"key":"2021052617251625200_dlz087-B29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/167.1.173","article-title":"Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring","volume":"167","author":"Bertino","year":"1993","journal-title":"J Infect Dis"},{"key":"2021052617251625200_dlz087-B30","first-page":"408","article-title":"Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines","volume":"157","author":"Davis","year":"1997","journal-title":"CMAJ"},{"key":"2021052617251625200_dlz087-B31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1742-7843.2011.00682.x","article-title":"The \u2018wise list\u2019 - a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm","volume":"108","author":"Gustafsson","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2021052617251625200_dlz087-B32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-017-2354-8","article-title":"Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee\u2019s list of recommended essential medicines (the \u2018Wise List\u2019)","volume":"74","author":"Eriksen","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"2021052617251625200_dlz087-B33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1525822X16640447","article-title":"How many interviews are enough to identify metathemes in multisited and cross-cultural research? Another perspective on Guest, Bunce, and Johnson\u2019s (2006) landmark study","volume":"29","author":"Hagaman","year":"2017","journal-title":"Field Methods"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/1\/dlz087\/38269223\/dlz087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/2\/1\/dlz087\/38269223\/dlz087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T18:49:16Z","timestamp":1622054956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlz087\/5716173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlz087","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,1,27]]},"article-number":"dlz087"}}